ArticlePreventive medicine reports2025
A descriptive study of blood pressure in people with self-reported substance use seeking health care in region F, Johannesburg, South Africa.
Article in Preventive medicine reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Background: Elevated blood pressure is a major risk factor for cardiovascular diseases like hypertension and leading cause of death in sub-Saharan Africa. Substance use such as alcohol, tobacco and drugs, is one of various factors attributable to elevated blood pressure This study describes the prevalence of elevated blood pressure and associated factors among individuals who self-reported to substance use. Methods: This descriptive cross-sectional study involved use of secondary data from the Integrating HIV and Heart Health in South Africa study collected between August 2022 to May 2024. Primary outcome, elevated blood pressure was classified as systolic blood pressure ≥ 140 mmHg, and diastolic blood pressure ≥ 90 mmHg. Data was analysed using STATA version 17. Logistic regression analysis was performed to identify factors associated with elevated blood pressure. Results: Of the 2148 participants included, 57.3 % (1230/2148) were males. The participants' median age was 41 years, and 35.9 % (772/2148) had elevated blood pressure, however only 16,9 % of the participants were receiving anti-hypertensive treatment. Independent factors associated with elevated blood pressure were increasing age - 30-39 years old (adjusted odds ratio (aOR) 2.78 [95 %CI 1.42-5.41], 40-49 years old (aOR 3.81 [95 %CI 1.95-7.46]), 50+ years (aOR 5.00 [95 %CI 2.45-10.20] and having comorbidities (aOR 2.35 [95 %CI 1.31-4.22]). Conclusions: Prevalence of elevated blood pressure was high and only a few of these were on anti-hypertensive treatment. Most participants reported using alcohol, including both alcohol and tobacco concurrently. Findings highlight the need for substance use interventions as part of cardiovascular disease management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.